Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Mainstay Prepares For CE Mark And European Launch Of Flagship Back-Pain Device

This article was originally published in Clinica

Executive Summary

Mainstay Medical expects the results of the ReActiv8-A trial to soon support a CE Mark for the ReActiv8 implantable stimulation system, allowing the Dublin-based company to launch the device in Europe beginning in Germany.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register